Tesamorelin / Ipamorelin Blend

Tesamorelin / Ipamorelin Blend

17mg
£76.50
Sale price  £76.50 Regular price 
Skip to product information
Tesamorelin / Ipamorelin Blend

Tesamorelin / Ipamorelin Blend

Dual peptide blend of Tesamorelin and Ipamorelin studied for combined GHRH / secretagogue research protocols.

- Form: Lyophilized powder
- Unit size: 17mg per vial (11mg + 6mg)
- Storage: Store at -20°C or lower

For research purposes only. Not for human or veterinary use.

Size17mg
✓ Multibuy Discount Available
Buy 2 save 5% Buy 3 save 10% Buy 4 save 15% Buy 5+ save 20%
£76.50
Sale price  £76.50 Regular price 
99%+ Purity Guaranteed
Same Day Dispatch · Royal Mail 24
Secure Checkout
⚠ For research purposes only. This product is not intended for human or veterinary use, consumption, or self-administration. By purchasing you confirm you are a qualified researcher or purchasing on behalf of a registered research facility. Read our full disclaimer →

Dual peptide blend of Tesamorelin and Ipamorelin studied for combined GHRH / secretagogue research protocols.

- Form: Lyophilized powder
- Unit size: 17mg per vial (11mg + 6mg)
- Storage: Store at -20°C or lower

For research purposes only. Not for human or veterinary use.

No batch is offered for sale until it has been analysed by an accredited third-party laboratory and reviewed against our internal acceptance criteria — HPLC purity analysis and mass spectrometry identity confirmation on every batch.

  • Long-term storage: −20°C or below, in an airtight container, protected from light
  • Short-term storage: 2–8°C for up to 4 weeks, if not yet reconstituted
  • Reconstituted solutions: store at 4°C and use within 48–72 hours, or aliquot and freeze at −80°C

Handling instructions are not provided beyond the above — products must be managed by qualified professionals in a suitable laboratory environment.

This product is supplied strictly for in-vitro laboratory research by qualified professionals in appropriate research settings. It is not intended for human or veterinary use, consumption, or self-administration, and has not been evaluated by the MHRA or any regulatory authority for therapeutic use.

Read the full disclaimer →

You may also like